Sep 2, 2025, 08:47
SUGAR Trial in Heart BMJ: Stent Outcomes in Patients With Diabetes Under the Spotlight
Heart BMJ posted on X:
”SUGAR and stents: evaluating long-term percutaneous coronary intervention outcomes in patients with diabetes”
Read the full articlle here.
Diabetes makes coronary disease more severe, with narrower, calcified vessels.
Patients with diabetes face higher risks after PCI — heart attack, stent problems, repeat procedures, death.
Risks exist even in silent or pre-diabetes.
Drug-eluting stents improved outcomes but risk stays higher vs. non-diabetics.
The SUGAR trial tested new stents in diabetes — no clear winner yet, but key insights for care.
Stay updated with Haemostasis Today.
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
-
Mar 13, 2026, 20:11Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
-
Mar 13, 2026, 19:53Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”
-
Mar 13, 2026, 17:21Emmanuel J Favaloro: Acquired Hemostasis Disorders Featured in New Issue of Seminars in Thrombosis and Hemostasis
-
Mar 13, 2026, 17:17Paolo Zamboni: New Insights from Australia on Jugular and Azygous Vein Chronic Obstruction
-
Mar 13, 2026, 17:06Srishti Goyal: Can Thalassemia Major Be Prevented?